Halozyme Therapeutics (HALO)

Add to Watchlists
Create an Alert
15.83 +0.60  +3.94% NASDAQ Mar 4, 1:50PM BATS Real time Currency in USD
View Full Chart
HALO Price Chart
View All Events

HALO Events

Date Type Description
01/07/2015 Misc Halozyme Therapeutics to Host Analyst and Investor Meeting
11/10/2014 16:30 EST Misc Halozyme Therapeutics Inc Q3 2014 Earnings Conference Call
11/10/2014 Earnings Halozyme Therapeutics Inc Q3 2014 Earnings Results
08/11/2014 16:30 EDT Misc Halozyme to Host Second Quarter 2014 Financial Results Conference Call
08/11/2014 Earnings Halozyme to Host Second Quarter 2014 Financial Results
05/13/2014 08:00 EDT Misc AGM Event for Halozyme Therapeutics Inc.
05/12/2014 16:30 EDT Misc Halozyme Therapeutics Inc Q1 2014 Earnings Conference Call
05/12/2014 Earnings Halozyme Therapeutics Inc Q1 2014 Earnings Results
View All Performance Charts

HALO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Halozyme Therapeutics is up 14.38% over the last year vs S&P 500 Total Return up 16.10%, Baxter International up 3.66%, and Egalet up 18.33%.

Get Quote for

PDF Report for HALO

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download HALO Pro Report PDF
Advertisement

Portfolio Strategies Featuring HALO

Did Halozyme Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

HALO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.halozyme.com
  • IR Website: http://www.halozyme.com/Investors/Investors/default.aspx
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: March 31, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Halozyme Therapeutics, Inc. is a biopharmaceutical company engaged in developing and commercializing innovative products that provide advanced patient care.

HALO Excel Add-In Codes

  • Name: =YCI("HALO","name")
  • Description: =YCI("HALO","description")
  • Sector: =YCI("HALO","sector")
  • Industry: =YCI("HALO","industry")
  • Est. Current Fiscal Year End: =YCI("HALO","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.